The predictive value of hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease

Biological Psychiatry

Volumn 39, Issue 11, 1996, Pages 976-978

  Swanwick, Gregory R J ^a,b   Coen, Robert F ^a   Walsh, J Bernard ^a   Coakley, Davis ^a   Lawlor, Brian A ^a  

^a ST JAMES S HOSPITAL   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Alzheimer's disease; Hypothalamic pituitary adrenal axis

Indexed keywords

HYDROCORTISONE;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; DEXAMETHASONE SUPPRESSION TEST; DISEASE COURSE; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; PREDICTION; PRIORITY JOURNAL;

EID: 0029887227     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00590-0     Document Type: Article

References (14)

1. Ball MJ, Fishman M, Hachinski V, et al (1985): A new definition of Alzheimer's disease: A hippocampal dementia. Lancet i:14-16.
2. Burns A, Jacoby R, Levy R (1991): Progression of cognitive impairment in Alzheimer's disease. J Am Geriatr Soc 39:39-45.
3. Davis KL, Davis BM, Greenwald BS, et al (1986): Cortisol and Alzheimer's disease: 1. Basal studies. Am J Psychiatry 143:300-305.
4. Ferrier N, Lester ES, Riordan DM, et al (1991): A follow-up study of elderly depressives and Alzheimer-type dementia-relationship with DST status. Int J Geriatr Psychiatry 6:279-286.
5. Folstein MF, Folstein SE, McHugh PR (1975): 'Mini-Mental State' : A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
6. Galasko D, Corey-Bloom J, Thal L (1991): Monitoring progression in Alzheimer's disease. J Am Geriatr Soc 39:932-941.
7. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982): A new scale for the staging of dementia. Br J Psychiatry 140:566-572.
8. McKeith IG (1984): Clinical use of the DST in a psychogeriatric population. Br J Psychiatry 145:389-393.
9. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
10. Miller AH, Sastry G, Speranza AJ, et al (1994): Dissociation between DST nonsuppression and cortisol hypersecretion in patients with Alzheimer's disease. Am J Psychiatry 151:267-270.
11. Raskind M, Peskind E, Rivard MF, Veith R, Barnes R (1982): Dexamethasone suppression test and cortisol circadian rhythm in primary degenerative dementia. Am J Psychiatry 139:1468-1470.
12. Sapolsky RM, McEwen BS (1986): Stress, glucocorticoids and their role in degenerative changes in the aging hippocampus. In Crook T, Bartus R, Ferris S, Gershon S (eds), Treatment Development Strategies for Alzheimer's Disease. New Canaan, CT: Mark Powley Associates, 151-171.
13. Stern RG, Mohs RC, Davidson M, et al (1994): A longitudinal study of Alzheimer's disease: Measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry 151:390-396.
14. Weiner MF, Vobach S, Svetlik D, Risser RC (1993): Cortisol secretion and Alzheimer's disease progression: A preliminary report. Biol Psychiatry 34:158-161.